ImmunoGen Inc (IMGN): ALLO, GILD… 04:57 09/18/20 Piper Sandler...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	59
Posts	18522
Boards Moderated	0
Alias Born	11/29/2006

realfast95

Re: None

Saturday, 09/19/2020 1:27:56 PM

Saturday, September 19, 2020 1:27:56 PM

ALLO, GILD… 04:57 09/18/20 Piper Sandler lays out next potential takeover targets in oncology Piper Sandler analysts highlighted what they believe are the next potential buyout targets in oncology following Gilead's (GILD) $21B purchase of Immunomedics (IMMU). Demand for high quality oncology assets remains high, says Piper, who notes the list covers companies with assets "that are both largely de-risked and target high value indications." The list includes Allogene Therapeutics (ALLO), ALX Oncology (ALXO), Aptose Biosciences (APTO), Blueprint Medicines (BPMC), Clovis (CLVS), Deciphera (DCPH), Fate Therapeutics (FATE), IGM Biosciences (IGMS), ImmunoGen (IMGN), Incyte (INCY), Iovance Biotherapeutics (IOVA), iTeos Therapeutics (ITOS), Kura Oncology (KURA), Mirati Therapeutics (MRTX), Seattle Genetics (SGEN), Sutro Biopharma (STRO), Syros Pharmaceuticals (SYRS), TCR2 Therapeutics (TCRR) and Xencor (XNCR).

Read more at:
https://thefly.com/n.php?id=3162407